Cost of dementia in Romania:  a cross-sectional Cost-of-Illness study undertaken in Bucharest

Vlad  Onetiu; Sorina Maria Aurelian; Ana Capisizu; Florina Cristescu; Ileana Codruta Zus; Katarzyna Kissimova-Skarbek

Tytuły

Cost of dementia in Romania: a cross-sectional Cost-of-Illness study undertaken in Bucharest

Abstrakt

Objective: The main aim of the research was to investigate the costs of dementia in Romania based on the estimated average cost of each person with dementia in Bucharest.

Method: This was across-sectional, non-population based study, with a mix of “bottom-up” and “top-down” data collection methods, which adopted the Cost-of-Illness approach from a broad societal perspective. The study involved 31 carers of patients with dementia in two Bucharest clinics in 2013 and 2014: the PROMEMORIA Private Clinic and the “Sf. Luca” chronic disease hospital. Face-to-face individual interviews were conducted using a modified version of the Resource Utilisation in Dementia (RUD) questionnaire. The average direct and indirect costs of dementia per person in the study were estimated for the year 2013 and are presented for the three levels of disease severity – mild, moderate and severe.

Results: The mean carer age was 59.3 (SD = 13.3), with 77.4% of the participants being females. The average cost (direct and indirect) of dementia per person in the study ranged from 53,787 RON to 67,554 RON (depending on the hourly wage used for valuation of the caregivers’ time). Converted to the international dollar currency, using the purchasing power parity (PPP) of the US dollar in Romania in 2013, the average cost of dementia in the study accounted for between I$32,301 and I$40,583. The estimated total annual cost of dementia in Romania in 2013 was between I$9 bln and I$11 bln.

Objective: The main aim of the research was to investigate the costs of dementia in Romania based on the estimated average cost of each person with dementia in Bucharest.

Method: This was across-sectional, non-population based study, with a mix of “bottom-up” and “top-down” data collection methods, which adopted the Cost-of-Illness approach from a broad societal perspective. The study involved 31 carers of patients with dementia in two Bucharest clinics in 2013 and 2014: the PROMEMORIA Private Clinic and the “Sf. Luca” chronic disease hospital. Face-to-face individual interviews were conducted using a modified version of the Resource Utilisation in Dementia (RUD) questionnaire. The average direct and indirect costs of dementia per person in the study were estimated for the year 2013 and are presented for the three levels of disease severity – mild, moderate and severe.

Results: The mean carer age was 59.3 (SD = 13.3), with 77.4% of the participants being females. The average cost (direct and indirect) of dementia per person in the study ranged from 53,787 RON to 67,554 RON (depending on the hourly wage used for valuation of the caregivers’ time). Converted to the international dollar currency, using the purchasing power parity (PPP) of the US dollar in Romania in 2013, the average cost of dementia in the study accounted for between I$32,301 and I$40,583. The estimated total annual cost of dementia in Romania in 2013 was between I$9 bln and I$11 bln.

Słowa kluczowe

demencja, choroba Alzheimera, opiekunowie, Rumunia, koszt choroby, koszty bezpośrednie, koszty pośrednie

dementia, Alzheimer’s disease, caregivers, Romania, cost of illness, direct costs, indirect costs

Bibliografia

Kerr D., Understanding learning disability and dementia – Developing effective interventions, Jessica Kingsley Publishers, London 2007.

Australian Department of Health, Dementia, https://health.gov.au/dementia, 2013; accessed: 09.04.2014.

World Health Organisation and Alzheimer’s Disease International, Dementia – a public health priority, WHO Press, Geneva 2012.

Atri A., Imaging of neurodegenerative cognitive and behavioural disorders: practical considerations for dementia clinical practice, “Handb. Clin. Neurol.” 2016; 136: 971–984.

Qiu C., Fratiglioni L., Epidemiology of the dementias, in: McNamara P. ed., Dementia – Volume 1: History and incidence, ABC-CLIO, LLC, Santa Barbara 2011.

Boustani M., Peterson B., Hason L., Harris R., Lohr K.N., Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force, “Ann. Intern. Med.” 2003; 138: 927–937.

Bayles K., Tomoeda C., Cognitive-communication disorders of dementia, Plural Publishing, Abingdon 2007.

Clare L., Neuropsychological rehabilitation and people with dementia, Psychology Press, Hove 2008.

Leifer B.P., Early diagnosis of Alzheimer’s Disease: Clinical and economic benefits, “Journal of the American Geriatrics Society” 2003; 51 (5s2): S281–S288.

Kitwood T., The experience of dementia, “Aging and Mental Health” 1997; 1 (1): 13–22.

European Parliament, Resolution of 19 January 2011 on a European initiative on Alzheimer’s Disease and other dementias, (2010 / 2084(INI)), 2011.

UNFPA, The state of world population 2011: People and possibilities in a world of 7 billion, UNFPA, New York 2011.

UN, World population ageing: 1950–2050, United Nations, New York 2001.

Alzheimer’s Disease International (ADI), Alzheimer’s Disease – Facts and Figures, “Alzheimer’s & Dementia” 2015; 11 (3): 332 ff.

Doraiswamy P.M., Leon J., Cummings J.L., Marin D., Neumann P.J., Prevalence and impact of medical comorbidity in Alzheimer’s disease, “J. Gerontol. A Biol. Sci. Med. Sci.” 2002; 57 (3): M173–M177.

NHS, Deaths from Alzheimer’s Disease, dementia and senility in England, http://www.endoflifecare-intelligence.org.uk/view?rid=88, 2010; accessed: 12.04.2014.

Xie J., Brayne C., Matthews F.E., Survival times in people with dementia: analysis from population based cohort study with 14 year follow up, “BMJ” 2008; 336: 258–262.

Helmer C., Joly P., Lentenneur L., Commenges D., Dartigueset J.-F., Mortality with dementia: results from a French prospective community-based cohort, “Am. J. Epidemiol.” 2001; 154 (7): 642–648.

Todd S., Barr S., Roberts M., Passmore A. P., Survival in dementia and predictors of mortality, “International Journal of Geriatric Psychiatry” 2013; 28 (11): 1109–1124.

Murray C.J., Vos T., Lozano R., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis of the Global Burden of Disease Study 2010, “Lancet” 2012; 380: 2197–2223.

Institute for Health Metrics and Evaluation (IHME), GBD 2015 Compare 1990–2015, http:// /vizhub.healthdata.org/gbd-compare/, 2016; accessed: 15.10.2016.

The Alzheimer’s Society US, Seven stages of Alzheimer’s, http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp, 2014; accessed: 09.10.2014.

Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J.L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens F., Tierney M.C., Whitehouse P., Winblad B., on behalf of the participants of the International Psychogeriatric Association Expert Conference on mild cognitive impairment, Mild Cognitive Impairment, “Lancet” 2006; 367: 1262–1270.

Iliffe S., Manthorpe J., The hazards of early recognition of dementia: A risk assessment, “Aging & Mental Health” 2004; 8 (2): 99–105.

Knapp M., Prince M., Dementia UK – The full report, The Alzheimer’s Society, London 2007.

Vernooij-Dassen M.J.F.J., Moniz-Cook E.D., Woods R.T., De Lepeleire J., Leuschner A., Zanetti O., de Rotrou J., Kenny G., Franco M., Peters V., Iliffe S., Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma, “International Journal of Geriatric Psychiatry” 2005; 20 (4): 377–386.

Boustani M., Callahan C.M., Unverzagt F.W., Austrom M.G., Perkins A.J., Fultz B.A., Hui S.L., Hendrie H.C., Implementing a screening and diagnosis program for dementia in primary care, “Journal of General internal Medicine” 2005; 20 (7): 572–577.

Barreto P. de S., Lapeyre-Mestre M., Mathieu C., Piau C., Bouget C., Cayla F., Vellas B., Rolland Y., The nursing home effect: a case study of residents with potential dementia and emergency department visits, “JAMDA” 2013; 14 (12): 901–905.

Lyketsos C.G., Steinberg M., Tschanz J.T., Norton M.C., Steffens D.C., Breitner J.C.S., Mental and behavioural disturbances in dementia. Finding from the Cache County Study on Memory in Aging, “American Journal of Psychiatry” 2000; 157 (5): 708–714.

Sampson E.L., Blanchard M.R., Jones L., Tookman A., King, M, Dementia in the acute hospital: prospective cohort study of prevalence and mortality, “The British Journal of Psychiatry” 2009; 195: 61–66.

Owen D., Diseased, demented, depressed: serious illness in Heads of State, “QJM” 2003; 96 (5): 325–336.

Middleton L., Yaffe K., Promising strategies for the prevention of dementia, “Arch. Neurol.” 2009; 66 (10): 1210–1215.

Gallagher J., G8 will develop dementia cure or treatment by 2025, http://www.bbc.com/news/health-25318194, 2013; accessed: 15.04.2014.

Byford S., Torgerson D.J., Raftery J., Cost of illness studies, “BMJ” 2000; 320 (7245): 1335.

Koopmanschap M.A., Cost-of-Illness Studies, “PharmacoEconomics” 1998; 14 (2): 143–148.

Heijink R., Renaud T., Cost-of-Illness Studies: a five-country methodological comparison, “Questions d’Economie de la Sante” 2009; 143: 1–6.

Currie G., Dymond K., Donaldson C., Macarthur C., Are cost of injury studies useful?, “Injury Prevention” 2000; 6 (3): 175–176.

McDaid D., Estimating the costs of informal care for people with Alzheimer’s disease: methodological and practical challenges, “International Journal of Geriatric Psychiatry” 2001; 16: 400–405.

Rice D.P., Cost of illness studies: what is good about them?, “Injury Prevention” 2000; 6: 177–179.

Costa N., Derumeaux H., Rapp T., Garnault V., Ferlicoq L., Gillette S., Methodological considerations in cost of illness studies on Alzheimer disease, “Health Economics Review” 2012; 2 (18): 1–12.

Cooper B., Rice D.P., The economic cost of illness revisited, “Soc. Secur. Bull.” 1976; 39 (2): 21–36.

Wimo A., Jonsson L., Winblad B., An estimate of the worldwide prevalence and direct costs of dementia in 2003, “Dement. Geriatr. Cogn. Disord.” 2006; 21: 175–181.

Kissimova-Skarbek K., Koszty obciążenia chorobami, in: Golinowska S. (ed.), Od ekonomii do ekonomiki zdrowia. Podręcznik ekonomiki zdrowia, PWN, Warszawa 2015: 354–391.

Drummond M.F., Sculpher M.J., Torrance G.W., O’Brian B.J., Stoddart G.L., Methods for the Economic Evaluation of Health Care Programmes, 3rd edition, Oxford University Press, Oxford–New York 2005.

Koopmanschap M., Burdorf A., Jacob K., Meerding W.J., Brouwer W., Severens H., Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda, “PharmacoEconomics” 2005; 23: 47–54.

Hutubessy R.C.W., van Tulder M.V., Vondeling H., Bouter L.M., Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method, “Pain” 1999; 80: 201–207.

Dagenais S., Caro J., Haldeman S., A systematic review of low back pain cost of illness studies in the United States and internationally, “The Spine Journal” 2008; 8: 8–20.

Ekman M., Johnell O., Lidgren L, The economic cost of low back pain in Sweden in 2001, “Acta Orthopaedica” 2005; 76 (2): 275–284.

Davis K.L., Marin D.B., Kane R., Patrick D., Peskind E.R., Raskind M.A., Puder K.L., The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer’s disease, “International Journal of Geriatric Psychiatry” 1997; 12 (10): 978–988.

Clipp C.C., Moore M.J., George L.K., The content and properties of the Caregiver Activities Time Survey (CATS): An outcome measure for use in clinical trial research on Alzheimer’s disease, “Am. J. Alzheimers Dis. Other Demen.” 1996; 11 (6): 3–9.

Wimo A., Jonsson L., Bond J., Prince M., Winblad B., The worldwide economic impact of dementia 2010, “Alzheimer’s & Dementia” 2013; 9 (1): 1–11.

Wimo A., Winblad B., Resource utilisation in dementia: RUD Lite, “Brain Aging” 2003; 3: 48–59.

Wimo A., Winblad B., Jonsson L., The worldwide societal costs of dementia: Estimates for 2009, “Alzheimer’s & Dementia” 2010; 6 (2): 98–103.

Wimo A., Nordberg G., Validity and reliability of assessments of time: Comparisons of direct observations and estimates of time by the use of the resource utilization in dementia (RUD) – instrument, “Archives of Gerontology and Geriatrics” 2007; 44 (1): 71–78.

Wimo A., Winblad B., Jonsson L., An estimate of the total worldwide societal costs of dementia in 2005, “Alzheimer’s & Dementia” 2007; 3 (2): 81–91.

Wimo A., Jonsson L., Gustavsson A., McDaid D., Ersek K., Georges J., Gulácsi L., Karpati K., Kenigsberg P., Valtonen H., The economic impact of dementia in Europe in 2008 – cost estimates from the Eurocode project, “Int. J. Geriatr. Psychiatry” 2011; 26 (8): 825–832.

Gerves C., Chauvin P., Bellanger M.M., Evaluation of full costs of care for patients with Alzheimer’s disease in France: The predominant role of informal care, “Health Policy” 2014; 116 (1): 114–1122.

Ersek K., Kovacs T., Wimo A. et al., Costs of Dementia in Hungary, “JNHA: Clinical Neurosciences” 2010; 14: 633–639.

Zencir M., Kuzu N., Gordeles Beser N., Ergin A., Catak B., Sahiner T., Cost of Alzheimer’s disease in a developing country setting, “International Journal of Geriatric Psychiatry” 2005; 20 (7): 616–622.

Gallagher T., Theft of a nation: Romania since communism, C. Hurst & Co. (publishers) Ltd, London 2005.

Dobos C., Dificultati de acces la serviciile publice de sanatate in Romania, “Calitatea Vietii” 2006; 17 (1–2): 7–24.

Zaman C., Inside the European Union: A diagnosis of the labour, market and social protection system in Romania at the moment of integration,http://ssrn.com/abstract=961816, 2007; accessed: 20.04.2014.

Hoff A., Tackling poverty and social exclusion of older people – lessons from Europe, Oxford Institute of Ageing, 2008, Working paper 308.

Vintila M., Marklinder I., Nydahl M., Istrat D., Kuglis A., Health awareness and behaviour of the elderly: between needs and reality, “Revista de Psihologie Aplicata” (“Journal of Applied Psychology”) 2009; 11 (2): 81–87.

INSSE (The Romanian National Institute of Statistics). Population census, http://colectaredate.insse.ro/phc/public.do?siteLang=en, 1992; accessed: 11.04.2014.

INSSE, Population census, http://colectaredate.insse.ro/phc/public.do?siteLang=en, 2002; accessed: 11.04.2014.

Eurostat database, http://ec.europa.eu/eurostat/data/database; accessed: 01.10.2016.

INSSE, Breviar statistic – sinteze (i.e. Yearly statistical breviary – synthesis), INSSE, Bucharest 2013.

European Commission and European Policy Committee, The 2012 Ageing Report – Economic and budgetary projections for the 27 EU member states (2010–2060), European Union, Bruxelles 2012.

Duthey B., Background paper 6.11 – Alzheimer Disease and other dementias, http://www.who.int/medicines/areas/priority_medicines/BP6_11Alzheimer.pdf, 2013; accessed: 10.04.2014.

Alzheimer’s Disease International, World Alzheimer Report 2010 – The global economic impact of dementia, http://www.alz.org/documents/national/world_alzheimer_report_ 2010.pdf, 2010; accessed: 09.04.2014.

World Bank, World Development Indicators, Last Updated Date 4.10.2016, GDP per capita, PPP (current international $) 2016, http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD; accessed: 10.10.2016.

World Bank, Health expenditure, total (% of GDP),: http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS, 2014; accessed: 15.10.2016.

Suciu M.C., Stan C.A., Piciorus L., Imbrisca C.I., Sistemul de saatate postcriza: efectele crizei economice in Romania, “Economie teoretica si aplicata” 2012; 5 (570): 129–142.

Sava D., Menon T., Romania: health sector policy note, World Bank Working Paper 2007; No 41545.

Solomon A., Dobranici L., Kareholt I., Tudose C., Lazarescu M., Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia, “International Journal of Geriatric Psychiatry” 2011; 26 (12): 1244–1251.

Romanian Alzheimer’s Society, Centrul Memoriei, http://www.alz.ro/centrul-memoriei.html, 2011; accessed: 14.04.2014.

Ana Aslan International Foundation, The Memory Clinic, http://www.brainaging.ro/en/clinics/, 2010; accessed: 14.04.2014.

PROMEMORIA, Despre noi (About us), http://www.pro-memoria.ro/desprenoi.html, 2014; accessed: 14.04.2014.

Tudose, C., Official Opening Ceremony of the National Alzheimer’s Conference, Introductory speech presented at the Romanian National Institute of Statistics, Bucharest, Romania, February 2014.

Romanian Alzheimer’s Society (RAS), The National Strategy for Dementia, especially with regard to the Alzheimer’s Disease, http://www.comunicatemedicale.ro/neurologie/2613-strategia-si-planul-national-pentru-demente-cu-precadere-dementa-din-boala-alzheimer-2014-2020/, 2014; accessed: 26.09.2016.

Department of Health, Prime Minister’s challenge on dementia, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215101/dh_133176.pdf, 2013; accessed: 14.04.2014.

Lustman F., National French plan for Alzheimer and related disorders 2008–2012, 2011, http://www.fightdementia.org.au/common/files/NAT/20110805_Nat_FrenchReport.pdf; accessed: 18.08.2016.

Saha S., Gerdtham U.G., Cost of illness studies on reproductive, maternal, newborn child health: a systematic literature review, “Health Economics Review” 2013; 3 (24): 3–24.

Avlund K., Schultz-Larsen K., Kreiner S., The measurement of instrumental ADL: content validity and construct validity, “Aging (Milano)” 1993; 5 (5): 371–383.

Ministry of Health, Order concerning the approval of methodological standards for the implementation of the Framework-Contract in 2013 regarding the supply of medical assistance within the 2013–2014 national social health insurance system, March 2013, no. 423/191.

The National Medicine Agency, Nomenclator, http://193.169. 156.200/app/nom1/anm_list.asp, 2014; accessed: 15.04.2014.

University Emergency Hospital in Bucharest, Tariff per day of hospitalisation, http://www.suub.ro/informatii/tarif-pe-ziua-de-spitalizare/, 2013; accessed: 26.09.2016.

Krol M., Productivity costs in economic evaluations. PhD Thesis, Erasmus University of Rotterdam 2012; accessed: 18.08.2016.

Van den Berg B., Brower W., Van Exel J., Koopmanschap M., van den Bos G.A.M., Rutten F., Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods, “Social Science & Medicine” 2006; 62: 835–845.

World Bank, World Development Indicators, GDP deflators; accessed: 12.10.2016.

World Bank, World Development Indicators, PPP conversion factor, GDP (Local Currency Unit per international $),
International Comparison Program database; accessed: 20.04.2016.

93. Alzheimer Europe, Romania (The prevalence of dementia in Europe), http://www.alzheimer-europe.org/Policy-in-Practice2/Country-comparisons/The-prevalence-of-dementia-in-Europe/Romania/(language)/eng-GB, 2012; accessed: 09.04.2014.

94. National Institute of Statistics, Sistemul conturilor de sanatate in Romania – anul 2011 (The Health Account System in Romania in 2011), http://www.insse.ro/cms/files/publicatii/sanatate/Sistemul%20Conturilor%20de%20Sanatate%20in%20anul%202011.pdf, 2013; accessed: 30.04.2014.

95. Alzheimer Europe, Regional and national cost of illness estimates, http://www.alzheimer-europe.org/Research/European-Collaboration-on-Dementia/Cost-of-dementia/Regional-National-cost-of-illness-estimates, 2008; accessed: 09.04.2014.

96. Romanian Census, Table on religious affiliation by regions, http://www.recensamantromania.ro/wp-content/uploads/2012/08/TS8.pdf, 2011; accessed: 23.04.2014.

97. OCP Media, The Holy Synod of the Romanian Orthodox Church in solemn meeting, http://theorthodoxchurch.info/blog/news/2012/12/the-holy-synod-of-the-romanian-orthodox-church-in-solemn-meeting-2/, 2012; accessed: 22.04.2014.

98. de Hennezel M., de Hennezel E., Qu’allons nous faire de vous?, Carnets Nord, Paris 2011.

99. Republique et Canton du Genev, Plan Alzheimer du canton du Geneve 2016–2019, http://www.ge.ch/deas/doc/communiques/2016-04-21--plan-Alzheimer-du-canton-GE-2016-2019.pdf, 2016; accessed: 01.10.2016.

100. Woods B., Dixon G.,Phillips M., Improving dementia care, http://www.1000livesplus.wales.nhs.uk/sitesplus/documents/1011/How%20to%20%2815%29%20Dementia%20%28Feb%202011%29%20Web.pdf, 2010; accessed: 24.04.2014.

Informacje

Informacje: Zdrowie Publiczne i Zarządzanie, 2016, Tom 14, Numer 3, s. 204 - 226

DOI: https://doi.org/10.4467/20842627OZ.16.023.5892

Typ artykułu: Oryginalny artykuł naukowy

Tytuły:

Polski:

Cost of dementia in Romania: a cross-sectional Cost-of-Illness study undertaken in Bucharest

Angielski:

Cost of dementia in Romania: a cross-sectional Cost-of-Illness study undertaken in Bucharest

Autorzy

Vlad Onetiu

Department of Health Economics and Social Security, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College; Public Health Wales

Sorina Maria Aurelian

“Sf. Luca" Chronic Disease Hospital in Bucharest

Ana Capisizu

“Sf. Luca" Chronic Disease Hospital in Bucharest

Florina Cristescu

Promemoria Private Clinic in Bucharest, Romania

Ileana Codruta Zus

Promemoria Private Clinic in Bucharest, Romania

Katarzyna Kissimova-Skarbek

Department of Health Economics and Social Security, Institute of Public Health, Department of Health Sciences, Jagiellonian University Medical College, Kraków

Publikacja: 30.11.2016

Status artykułu: Otwarte

Licencja: Żadna

Udział procentowy autorów:

Vlad Onetiu (Autor) - 16%

Sorina Maria Aurelian (Autor) - 16%

Ana Capisizu (Autor) - 16%

Florina Cristescu (Autor) - 16%

Ileana Codruta Zus (Autor) - 16%

Katarzyna Kissimova-Skarbek (Autor) - 20%

Korekty artykułu:

-

Języki publikacji:

Angielski

Liczba wyświetleń: 2390

Liczba pobrań: 1270

<p> Cost of dementia in Romania: a cross-sectional Cost-of-Illness study undertaken in Bucharest</p>

Pobierz pełny tekst

Tytuły

Abstrakt

Słowa kluczowe

Bibliografia

Informacje

Autorzy